Education
About Us
Working with TipRanks
Follow Us
MustGrow Biologics (MGROF)
OTHER OTC:MGROF
Total Valuation
MustGrow Biologics has a market cap or net worth of $25.38M. The enterprise value is $44.59M.
Market Cap$25.38M
Enterprise Value$44.59M
Share Statistics
MustGrow Biologics has 51,640,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding51,640,610
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MustGrow Biologics’s return on equity (ROE) is -2.25 and return on invested capital (ROIC) is -175.56%.
Return on Equity (ROE)-2.25
Return on Assets (ROA)-0.90
Return on Invested Capital (ROIC)-175.56%
Return on Capital Employed (ROCE)-2.03
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.07
Inventory Turnover0.07
Valuation Ratios
The current PE Ratio of MustGrow Biologics is ―. MustGrow Biologics’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value27.35
Price to FCF―
Price to Operating Cash Flow-6.39
PEG Ratio―
Income Statement
In the last 12 months, MustGrow Biologics had revenue of 398.02K and earned -4.89M in profits. Earnings per share was -0.09.
Revenue398.02K
Gross Profit300.75K
Operating Income-5.11M
Pretax Income-4.89M
Net Income-4.89M
EBITDA-5.11M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was -5.55M and capital expenditures -21.63K, giving a free cash flow of -5.57M billion.
Operating Cash Flow-5.55M
Free Cash Flow-5.57M
Free Cash Flow per Share-0.11
Dividends & Yields
MustGrow Biologics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.84
52-Week Price Change-26.15%
50-Day Moving Average0.56
200-Day Moving Average0.80
Relative Strength Index (RSI)35.66
Average Volume (3m)1.04K
Important Dates
MustGrow Biologics upcoming earnings date is Dec 2, 2025, During Market Hours (Confirmed).
Last Earnings DateAug 27, 2025
Next Earnings DateDec 2, 2025
Ex-Dividend Date―
Financial Position
MustGrow Biologics as a current ratio of 1.61, with Debt / Equity ratio of -1651.14%
Current Ratio1.61
Quick Ratio1.12
Debt to Market Cap<0.01
Net Debt to EBITDA0.48
Interest Coverage Ratio0.00
Taxes
In the past 12 months, MustGrow Biologics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MustGrow Biologics EV to EBITDA ratio is -11.12, with an EV/FCF ratio of -15.89.
EV to Sales142.85
EV to EBITDA-11.12
EV to Free Cash Flow-15.89
EV to Operating Cash Flow-15.89
Balance Sheet
MustGrow Biologics has $1.82M in cash and marketable securities with $3.14M in debt, giving a net cash position of $1.32M billion.
Cash & Marketable Securities$1.82M
Total Debt$3.14M
Net Cash$1.32M
Net Cash Per Share$0.03
Tangible Book Value Per Share$0.03
Margins
Gross margin is 20.44%, with operating margin of -1284.91%, and net profit margin of -1228.27%.
Gross Margin20.44%
Operating Margin-1284.91%
Pretax Margin-1228.27%
Net Profit Margin-1228.27%
EBITDA Margin-1284.91%
EBIT Margin-1228.27%
Analyst Forecast
The average price target for MustGrow Biologics is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―